Hypertrophic Cardiomyopathy and Valve Center Heart and Vascular Institute Cleveland Clinic Cleveland OH.
J Am Heart Assoc. 2021 Sep 21;10(18):e018435. doi: 10.1161/JAHA.120.018435. Epub 2021 Sep 17.
Background Hypertrophic cardiomyopathy (HCM) and aortic stenosis can cause obstruction to the flow of blood out of the left ventricular outflow tract into the aorta, with obstructive HCM resulting in dynamic left ventricular outflow tract obstruction and moderate or severe aortic stenosis causing fixed obstruction caused by calcific degeneration. We sought to report the characteristics and longer-term outcomes of patients with severe obstructive HCM who also had concomitant moderate or severe aortic stenosis requiring surgical myectomy and aortic valve replacement. Methods and Results We studied 191 consecutive patients (age 67±6 years, 52% men) who underwent myectomy and aortic valve (AV) replacement (90% bioprosthesis) at our center between June 2002 and June 2018. Clinical and echo data including left ventricular outflow tract gradient and indexed AV area were recorded. The primary outcome was death. Prevalence of hypertension (63%) and hyperlipidemia (75%) were high, with a Society of Thoracic Surgeons score of 5±4, and 70% of participants had no HCM-related sudden death risk factors. Basal septal thickness and indexed AV area were 1.9±0.4 cm and 0.72±0.2 cm/m, respectively, while 100% of patients had dynamic left ventricular outflow tract gradient >50 mm Hg. At 6.5±4 years, 52 (27%) patients died (1.5% in-hospital deaths). One-, 2-, and 5-year survival in the current study sample was 94%, 91%, and 83%, respectively, similar to an age-sex-matched general US population. On multivariate Cox survival analysis, age (hazard ratio [HR], 1.65; 95% CI, 1.24-2.18), chronic kidney disease (HR, 1.58; 95% CI, 1.21-2.32), and right ventricular systolic pressure on preoperative echocardiography (HR, 1.28; 95% CI, 1.05-1.57) were associated with longer-term mortality, but traditional HCM risk factors did not. Conclusions In symptomatic patients with severely obstructive HCM and moderate or severe aortic stenosis undergoing a combined surgical myectomy and AV replacement at our center, the observed postoperative mortality was significantly lower than the expected mortality, and the longer-term survival was similar to a normal age-sex-matched US population.
肥厚型心肌病(HCM)和主动脉瓣狭窄可导致左心室流出道血液流出进入主动脉受阻,其中梗阻性 HCM 导致左心室流出道动力性梗阻,而中重度主动脉瓣狭窄导致由钙化变性引起的固定性梗阻。我们旨在报告同时伴有需要外科心肌切除术和主动脉瓣置换术的中重度主动脉瓣狭窄的严重梗阻性 HCM 患者的特征和长期结局。
我们研究了 191 例连续患者(年龄 67±6 岁,52%为男性),他们于 2002 年 6 月至 2018 年 6 月在我们中心接受了心肌切除术和主动脉瓣(AV)置换术(90%为生物瓣)。记录了临床和超声心动图数据,包括左心室流出道梯度和指数化 AV 面积。主要结局为死亡。高血压(63%)和高血脂(75%)的患病率较高,胸外科医生评分(STS)为 5±4,70%的患者没有 HCM 相关的猝死危险因素。基底室间隔厚度和指数化 AV 面积分别为 1.9±0.4cm 和 0.72±0.2cm/m,而 100%的患者存在>50mmHg 的动力性左心室流出道梯度。在 6.5±4 年时,有 52 例(27%)患者死亡(院内死亡率为 1.5%)。本研究样本的 1、2 和 5 年生存率分别为 94%、91%和 83%,与年龄和性别匹配的一般美国人群相似。多变量 Cox 生存分析显示,年龄(危险比[HR],1.65;95%置信区间[CI],1.24-2.18)、慢性肾脏病(HR,1.58;95%CI,1.21-2.32)和术前超声心动图右心室收缩压(HR,1.28;95%CI,1.05-1.57)与长期死亡率相关,但传统的 HCM 危险因素则不然。
在我们中心接受外科心肌切除术和 AV 置换术联合治疗的严重梗阻性 HCM 且伴有中重度主动脉瓣狭窄的症状性患者中,观察到的术后死亡率明显低于预期死亡率,且长期生存率与正常年龄和性别匹配的美国人群相似。